Organigram is a licensed cannabis producer based in Moncton, New Brunswick. It partnered with British American Tobacco in 2023 to develop new cannabis products and also bought The Edibles and ...

Q3 2025 Earnings Call Transcript August 13, 2025 Organigram Global Inc. misses on earnings expectations. Reported EPS is ...

OrganiGram Holdings ( ($OGI) ) has released its Q3 earnings. Here is a breakdown of the information OrganiGram Holdings presented to its ...

Beena Goldenberg, CEO of Organigram Global, joins BNN Bloomberg to discuss the company's acquisition of Motif as their outlook for the future.

Organigram's Q3 sales rose 72% to $51.14 million, driven by Motif acquisition and global demand, with margin gains and positive cash flow expected.

TORONTO (AP) — TORONTO (AP) — Organigram Global Inc. (OGI) on Wednesday reported a loss of $4.5 million in its fiscal third quarter. On a per-share basis, the Toronto-based company said it had a loss ...

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market ...

Analysts expect OrganiGram Holdings to report an earnings per share (EPS) of $-0.01. The announcement from OrganiGram Holdings is eagerly anticipated, with investors seeking news of surpassing ...

Organigram Global Inc. (NASDAQ:OGI), a leading Canadian cannabis producer, is accelerating its international expansion with a ...

Organigram is focused on producing high-quality cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company's global footprint.

OG Investor Session includes presentations from Organigram Global’s senior leadership team, tours of its five state-of-the-art facilities, and a live investor Q&A session Organigram Global Inc ...

Browse here. “The highly complementary acquisition of Motif establishes Organigram as Canada’s largest cannabis company by market share and accelerates our vision to be a leading cannabis company ...